Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT01077986 · COMPLETED
Trial details
- NCT number
- NCT01077986
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-08-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.